UK's Glaxo Smith Kline Aims to Market First Malaria Vaccine
October 8, 2013
Reuters / Powered by NewsLook.com
British drug maker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed it significantly cut cases of the disease in African children. As Joanna Partridge reports it will be welcome news for a UK company recently battered by a corruption scandal in China.
AFP (Apr. 24, 2014) World Malaria Day is commemorated every year on April 25 and recognizes global efforts to control malaria. Seasonal malaria chemoprevention is a new prevention strategy for Niger. Duration: ... watch video
AFP (Oct. 8, 2013) Experts in Africa, the continent worst-hit by malaria, reacted with optimism but also caution on Tuesday at hopes that the first vaccine against the killer disease may soon reach the market. ... watch video
Reuters - Innovations Video Online (May 2, 2016) An over the counter kit used to test for malaria at home using a patient's urine could make a substantial impact in the global fight to eliminate malaria by 2030.
Video provided by ... watch video
Reuters - News Video Online (Apr. 24, 2015) The world's first anti-malaria vaccine could get the go-ahead for use in Africa from October if approved by international regulators. Paul Chapman reports.
Video provided by ... watch video
AFP (July 24, 2015) The world's most advanced malaria vaccine got the nod Friday from European regulators, despite mixed trial results, for eventual use in children in African countries plagued by the killer ... watch video
Reuters (Aug. 5, 2013) Israeli drug company SciVac has developed a third-generation vaccine for Hepatitis B, a virus that kills more than half a million people each year. The company says the vaccine has the potential to ... watch video
Aug. 30, 2016 Healthy fat tissue is essential for extended survival in the event of tumor-induced wasting syndrome (cachexia). Researchers have shown that selective manipulation of an enzyme can stop unwanted ... read more
Aug. 29, 2016 The glucocentric focus on lowering blood sugar in type 2 diabetes may have short-circuited development of new diabetes therapies, according to a new paper. Overall, the authors suggest that the ... read more
Aug. 30, 2016 Researchers are working to find the fastest way possible to treat and cure human African trypanosomiasis, long referred to as sleeping sickness. Human African trypanosomiasis, or HAT, is a tropical ... read more
Apr. 12, 2016 Although the World Health Organization decided not to recommend the use of RTS,S/AS01, the most advanced malaria vaccine candidate that is in development, in infants within the Expanded Programme of ... read more
Apr. 23, 2015 The first malaria vaccine candidate (RTS,S/AS01) to reach phase 3 clinical testing is partially effective against clinical disease in young African children up to 4 years after vaccination, according ... read more
July 29, 2014 A vaccine previously shown to reduce malaria in young infants and children reduces larger numbers of malaria cases in areas of higher malaria transmission, according to results from an ongoing ... read more
May 7, 2014 Although malaria kills some 600,000 African children each year, most cases of the mosquito-borne parasitic disease in children are mild. Repeated infection does generate some immunity, and episodes ... read more